1、该刊只有国际刊号。

2、投稿方式：官网投稿。

3、官网网址：

https://journal.hep.com.cn/ent/EN/home

4、投稿系统：

https://mc.manuscriptcentral.com/entdiscovery

5、官网电话：021-64377134

6、官网邮箱：entdiscovery@fudan.edu.cn

7、出刊日期：季刊，一年出版四期。

8、官方微信公众号：ENT Discovery

2025年11月25日星期二

Guidelines for authors

【官网信息】

ENT Discovery

Guidelines for authors

1 General Introduction

ENT

Discovery (ENTD) is a dynamic platform dedicated to pioneering research

and clinical innovations in otorhinolaryngology. The journal champions

an interdisciplinary approach, integrating cutting-edge technologies,

novel therapies, and surgical advancements to drive the field forward.

We welcome original discoveries, translational studies, and clinical

insights that advance the diagnosis and treatment of ENT disorders. For

more information about the journal’s focus and coverage, please refer to

the Aims & Scope. The journal is published online. Online versions

are available at https://journal.hep.com.cn/ent.

2 Publication Ethics and Integrity

Once

the submission materials have been prepared in accordance with the

Author Guidelines, manuscripts should be submitted online at

https://mc.manuscriptcentral.com/entdiscovery.

For help with submissions, please contact: entdiscovery@pub.hep.cn

2.1 Types of articles

l Original Article

Original

Articles present novel research findings or conceptual analyses that

make a substantial contribution to the field’s knowledge base.

l Review

Review

Articles provide a comprehensive synthesis of developments in a field

or current lines of thought, drawing on multiple sources of information

and extensive referencing; the emphasis is on factual analysis rather

than purely opinion.

l Case Report

Case

Reports describe the detailed clinical presentation, diagnosis,

treatment and follow-up of an individual patient (or a small case

series) and typically highlight an unusual or novel occurrence or

provide substantial learning value for the readership.

l Guideline

Guideline

Articles provide evidence-based analyses and recommendations on issues

relevant to clinical practice, health care management, public health or

health policy.

l Perspective

Perspective

Articles offer a forum for authors to present models, ideas or

viewpoints on a specific area, typically reflecting personal insight or

future directions rather than primary research.

l Commentary

Commentary

Articles are evidence-based opinion pieces on topics of broad interest,

often invited, providing critique, commentary or interpretation rather

than original data.

l News

News

items provide factual, timely information and updates on relevant

events, research highlights or developments outside the primary

peer-reviewed article structure.

l Editorial

Editorials

are short pieces written by the Editor-in-Chief or a commissioned

guest, conveying an opinion or overview on an issue of topical or

strategic relevance to the journal and its readership.

2.2 Submission Requirements

l

Type Select the appropriate article type according to “2.1 Types of

articles”. Ensure that the content and structure of your manuscript

align with the selected article type.

l

Title Provide a concise and informative title reflecting the content

and key findings of the manuscript. Avoid abbreviations and formulae

where possible.

l

Abstract The abstract should briefly summarize the objectives, methods,

main results, and conclusions of the study. It must be self-contained

and should not contain references or undefined abbreviations.

l

Files All manuscript files must be clearly named and uploaded to their

corresponding sections. Ensure that the file names indicate their

content (e.g., “Figure 1,” “Table 2,” “Supplementary file”). Files

include the several following types:

l

Main Document The main text should be uploaded as a Microsoft Word

(.doc or .docx) file. It should include the title, abstract, keywords,

main text, references, and figure/table legends. Further details

regarding manuscript structure and ethical standards can be found in the

“Ethical requirements” section.

l

Figure should be of high resolution (at least 300 dpi) and submitted as

separate files in TIFF, JPEG, or PNG format. Each figure must be

clearly numbered and cited in the text. Composite figures should be

labeled (A, B, C…) consistently. Please include figure titles or legends

in the Main Document.

l

Table Tables should be included in the Main Document or uploaded

separately in Word or Excel format. Use clear, concise titles and

include explanatory footnotes when necessary. Each table must be clearly

numbered and cited in the text. Please include table titles or legends

in the Main Document.

l

Supplemental file for Review Supplementary materials intended for

review (e.g., additional data, methods, or figures) should be uploaded

in this section. These files will be accessible to reviewers but may not

appear in the final publication.

l

Supplemental file NOT for Review Confidential materials (e.g., conflict

of interest forms, or ethical approval documents) should be uploaded

here. These will not be shared with reviewers.

l Title Page A separate title page should include the following:

1. Full title of the manuscript

2. Running title

3. Full names of all authors and their institutional affiliations

4. Corresponding author’s name, address, and e-mail

l

Keywords Provide 3–8 keywords that accurately reflect the topic of the

manuscript. Use terms that are searchable and standardized.

l

Authors & Institutions List all authors in the correct order with

their institutional affiliations, department names, city, and country.

Example format:

Author’s name, Department of Otorhinolaryngology, Head and Neck Surgery, [Institution Name], [City], [Country]

Corresponding

author’s name, Department of Otorhinolaryngology, Head and Neck

Surgery, [Institution Name], [City] [Postal Code], [Country], E-mail:

email address.

l

Reviewers Authors are encouraged to recommend or oppose up to three

potential reviewers who have relevant expertise and no conflicts of

interest. Please include each reviewer’s name, e-mail address,

institution, department, and phone number. The final selection of

reviewers rests with the Editorial Office.

l Details & Comments

l

Cover Letter A cover letter should be included in the ‘Cover Letter

Field’ of the ScholarOne system. The text can be entered directly into

the field or uploaded as a file.

The cover letter must contain:

i)

A statement confirming the paper has not been published or submitted

for publication elsewhere except as a brief abstract in the proceedings

of a scientific meeting or symposium;

ii)

An acknowledgment that all authors have contributed significantly and

in keeping with the latest guidelines of the International Committee of

Medical Journal Editors, each author’s contribution to the paper is to

be described, i.e., what role each author participated in;

iii) a statement confirming that all authors are in agreement with the content of the manuscript.

l

Funding Is there funding to report for this submission? If yes, please

choose “Yes” provide information on all sources of financial support,

including name, grant/award numbers and funding agencies. If no specific

funding was received, please choose “No”.

l

Manuscript Details Enter general information such as Number of words,

Number of manuscript pages, Number of tables, and Total number of

figures. Authors should ensure that the selected article type matches

the content and structure of the submission.

l

Submission Information Confirm that the manuscript has been submitted

solely to this journal and is not published, in press, or submitted

elsewhere.

l

Conflict of Interest ENT Discovery requires that all authors disclose

any potential sources of conflict of interest. Any interest or

relationship, financial or otherwise, that might be perceived as

influencing an author’s objectivity is considered a potential source of

conflict of interest. These must be disclosed when directly relevant or

indirectly related to the work that the authors describe in their

manuscript. Potential sources of conflict of interest include but are

not limited to patent or stock ownership, membership of a company board

of directors, membership of an advisory board or committee for a

company, and consultancy for or receipt of speaker’s fees from a

company. The existence of a conflict of interest does not preclude

publication in this journal.

If

the authors have no conflict of interest to declare, they must also

state this at submission. It is the responsibility of the corresponding

author to review this policy with all authors and to collectively list

in the cover letter (if applicable) to the Editor-in-Chief, in the

manuscript (in the footnotes, Conflict of Interest or Acknowledgments

section), and in the online submission system ALL pertinent commercial

and other relationships.

l Previously Submitted Has this manuscript previously

-

been submitted via this submission website and received a revision

decision [revised papers should be submitted as “revisions” and not as

“new” papers]

- been submitted outside of this website and is now being submitted after revision

- been submitted to this publication and been rejected?

If

any of the above is true please answer "Yes". If yes, please state

previous Manuscript ID in the ‘Previously Submitted Field’ of the

ScholarOne system.

l

Author License Agreement(s) Confirm that all authors of this submission

have understood the journal's licensing policy. Further information

about the journal's license agreement(s) and Terms of Use can be found

in 2.4 Copyright & OA Licensing in following part and Editorial

policy.

2.3 Duplicate Publication and Plagiarism

We

only accept original, unpublished manuscripts that have not been

submitted simultaneously to other journals. By submitting a manuscript,

authors agree to this policy. As defined by the World Association of

Medical Editors (WAME), plagiarism is the use of others' published or

unpublished ideas, words, or other intellectual property without

attribution or permission. The intent and effect of plagiarism are to

mislead the reader as to the contributions of the plagiarizer. This

applies whether the material is taken from abstracts, research grants,

or published or unpublished manuscripts. The editorial office uses

plagiarism detection software, such as iThenticate, to screen all

submissions. Any allegations of plagiarism are investigated in

accordance with the Committee on Publication Ethics (COPE) guidelines.

If plagiarism is detected at any point, appropriate actions will be

taken, which may include notifying the authors' institution and funding

agencies, and potentially retracting the published paper. For additional

information, please visit http://www.publicationethics.org.

2.4 After Acceptance

l First Look

After

your paper is accepted, your files will be assessed by the editorial

office to ensure they are ready for production. You may be contacted if

any updates or final files are required. Otherwise, your paper will be

sent to the production team.

l Copyright & OA Licensing

ENT

Discovery is an open access journal. All articles published in this

journal are freely and permanently available online immediately upon

publication. Readers are allowed to read, download, copy, distribute,

print, search, or link to the full texts of articles without prior

permission from the publisher or the author. All published articles are

licensed under the Creative Commons Attribution License (CC-BY).This

license permits unrestricted use, distribution, and reproduction in any

medium, provided the original work is properly cited. Authors retain the

copyright of their work. For more information, please visit

https://creativecommons.org/licenses/by/4.0/. Note that certain funders

mandate a particular type of CC license be used. For more information on

this journal’s APCs, please see Open Access in “Editorial Policy”.

Upon

acceptance, authors are required to complete the OA Agreement to

confirm the transfer of publishing rights and acknowledge the terms of

the CC BY license. Authors should ensure that all listed co-authors have

approved the final version of the manuscript and agree to its

submission.

OA Agreement Procedure:

1. After your manuscript has been accepted, please log into the ScholarOne Manuscripts system.

2. Download the original OA Agreement file provided in your author center.

3. Print and sign the document (an electronic signature is acceptable).

4.

Upload the signed agreement (PDF or scanned copy) to the designated

section in ScholarOne to complete the authorization process.

Failure to complete this step may result in a delay in publication.

For further information or assistance, please contact the editorial office at entdiscovery@pub.hep.cn.

l Proofs

Authors

will receive an e-mail notification with a link and instructions for

accessing HTML page proofs online/with their proofs included as a pdf.

Authors should also make sure that any renumbered tables, figures, or

references match text citations and that figure legends correspond with

text citations and actual figures. Proofs must be returned within 72

hours of receipt of the email.

Pubdate: Jul 18, 2025